Literature DB >> 21985785

Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.

Simon Schenk1, Carrie E McCurdy, Andrew Philp, Mark Z Chen, Michael J Holliday, Gautum K Bandyopadhyay, Olivia Osborn, Keith Baar, Jerrold M Olefsky.   

Abstract

Skeletal muscle insulin resistance is a key component of the etiology of type 2 diabetes. Caloric restriction (CR) enhances the sensitivity of skeletal muscle to insulin. However, the molecular signals within skeletal muscle linking CR to improved insulin action remain largely unknown. Recently, the mammalian ortholog of Sir2, sirtuin 1 (Sirt1), has been identified as a potential transducer of perturbations in cellular energy flux into subsequent metabolic adaptations, including modulation of skeletal muscle insulin action. Here, we have demonstrated that CR increases Sirt1 deacetylase activity in skeletal muscle in mice, in parallel with enhanced insulin-stimulated phosphoinositide 3-kinase (PI3K) signaling and glucose uptake. These adaptations in skeletal muscle insulin action were completely abrogated in mice lacking Sirt1 deacetylase activity. Mechanistically, Sirt1 was found to be required for the deacetylation and inactivation of the transcription factor Stat3 during CR, which resulted in decreased gene and protein expression of the p55α/p50α subunits of PI3K, thereby promoting more efficient PI3K signaling during insulin stimulation. Thus, these data demonstrate that Sirt1 is an integral signaling node in skeletal muscle linking CR to improved insulin action, primarily via modulation of PI3K signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985785      PMCID: PMC3204844          DOI: 10.1172/JCI58554

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity.

Authors:  Asensio A Gonzalez; Reetu Kumar; Jacob D Mulligan; Ashley J Davis; Richard Weindruch; Kurt W Saupe
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07-13       Impact factor: 4.310

2.  Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation following endurance exercise.

Authors:  Andrew Philp; Ai Chen; Debin Lan; Gretchen A Meyer; Anne N Murphy; Amy E Knapp; I Mark Olfert; Carrie E McCurdy; George R Marcotte; Michael C Hogan; Keith Baar; Simon Schenk
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  Adaptation of muscle glucose transport with caloric restriction in adult, middle-aged, and old rats.

Authors:  G D Cartee; E W Kietzke; C Briggs-Tung
Journal:  Am J Physiol       Date:  1994-05

4.  Insulin-stimulated translocation of glucose transport systems in the isolated rat adipose cell. Time course, reversal, insulin concentration dependency, and relationship to glucose transport activity.

Authors:  E Karnieli; M J Zarnowski; P J Hissin; I A Simpson; L B Salans; S W Cushman
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

5.  Calorie restriction increases muscle insulin action but not IRS-1-, IRS-2-, or phosphotyrosine-PI 3-kinase.

Authors:  Robert T Davidson; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-02       Impact factor: 4.310

6.  Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling.

Authors:  Kohjiro Ueki; David A Fruman; Claudine M Yballe; Mathias Fasshauer; Johannes Klein; Tomoichiro Asano; Lewis C Cantley; C Ronald Kahn
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

7.  p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.

Authors:  Dong Chen; Franck Mauvais-Jarvis; Matthias Bluher; Simon J Fisher; Alison Jozsi; Laurie J Goodyear; Kohjiro Ueki; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.

Authors:  Hwei-Ling Cheng; Raul Mostoslavsky; Shin'ichi Saito; John P Manis; Yansong Gu; Parin Patel; Roderick Bronson; Ettore Appella; Frederick W Alt; Katrin F Chua
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

9.  Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.

Authors:  Linda A Barbour; Jianhua Shao; Liping Qiao; Wayne Leitner; Marianne Anderson; Jacob E Friedman; Boris Draznin
Journal:  Endocrinology       Date:  2003-11-21       Impact factor: 4.736

10.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  95 in total

1.  Diabetes: insulin signal meets SIRT1 at AKT.

Authors:  Yoshiyuki Horio
Journal:  Nat Rev Endocrinol       Date:  2011-11-22       Impact factor: 43.330

2.  Sirtuins and calorie restriction.

Authors:  Leonard Guarente
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-29       Impact factor: 94.444

3.  Calorie restriction leads to greater Akt2 activity and glucose uptake by insulin-stimulated skeletal muscle from old rats.

Authors:  Haiyan Wang; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

Review 4.  The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.

Authors:  S Imai; J Yoshino
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

5.  Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells.

Authors:  Valérie Desquiret-Dumas; Naïg Gueguen; Géraldine Leman; Stéphanie Baron; Valérie Nivet-Antoine; Stéphanie Chupin; Arnaud Chevrollier; Emilie Vessières; Audrey Ayer; Marc Ferré; Dominique Bonneau; Daniel Henrion; Pascal Reynier; Vincent Procaccio
Journal:  J Biol Chem       Date:  2013-10-31       Impact factor: 5.157

6.  Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.

Authors:  M Y Kim; J H Lim; H H Youn; Y A Hong; K S Yang; H S Park; S Chung; S H Ko; S H Koh; S J Shin; B S Choi; H W Kim; Y S Kim; J H Lee; Y S Chang; C W Park
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

Review 7.  Metabolic regulation of Sirtuins upon fasting and the implication for cancer.

Authors:  Yueming Zhu; Yufan Yan; David R Gius; Athanassios Vassilopoulos
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

8.  One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance.

Authors:  Mei Hua Gao; Dimosthenis Giamouridis; N Chin Lai; Evelyn Walenta; Vivian Almeida Paschoal; Young Chul Kim; Atsushi Miyanohara; Tracy Guo; Min Liao; Li Liu; Zhen Tan; Theodore P Ciaraldi; Simon Schenk; Aditi Bhargava; Da Young Oh; H Kirk Hammond
Journal:  JCI Insight       Date:  2016-09-22

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

10.  Neuronal Sirt1 deficiency increases insulin sensitivity in both brain and peripheral tissues.

Authors:  Min Lu; David A Sarruf; Pingping Li; Olivia Osborn; Manuel Sanchez-Alavez; Saswata Talukdar; Ai Chen; Gautam Bandyopadhyay; Jianfeng Xu; Hidetaka Morinaga; Kevin Dines; Steven Watkins; Karl Kaiyala; Michael W Schwartz; Jerrold M Olefsky
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.